Toggle Nav
Close
  • Menu
  • Setting

Recombinant Human Sonic Hedgehog/Shh

Catalog No.
PH2047
Recombinant Human Sonic Hedgehog/Shh
Grouped product items
SizePriceStock Qty
10ug
$150.00
In stock
100ug
$547.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Sonic Hedgehog (Shh) is expressed in embryonic tissues that are critical for the patterning of the developing central nervous system, somite, and limb. It is also involved in whisker, hair, foregut, tooth, and bone development. Shh regulates neural and hematopoietic stem cell fate and is important for thymocyte differentiation and proliferation as well as T cell determination. In adult tissue Shh is associated with cancer development and tissue remodeling following injury [1-3]. Human Shh encodes a 462 amino acid (aa) precursor protein that is autocatalytically processed to yield a non-glycosylated 19 kDa N-terminal fragment (Shh-N) and a glycosylated 25 kDa C-terminal protein (Shh-C) [4]. Shh-C, which is responsible for the intramolecular processing of Shh, is rapidly degraded following Shh proteolysis [5]. Shh-N is highly conserved, sharing >98% aa identity between mouse, human, rat, canine, porcine, and chicken Shh-N. Shh-N can be palmitoylated at its N-terminal cysteine and modified by cholesterol addition at its C-terminus [6]. These modifications contribute to the membrane tethering of Shh as well as its assembly into various sized multimers [6-9]. Lipid modification and multimerization greatly increase Shh-N receptor binding affinity and signaling potency [5, 6, 8, 9]. Monomeric and multimeric Shh can be released from the plasma membrane by the cooperative action of DISP1, SCUBE2, and TACE/ADAM17 [10-12]. Modifications also extend the effective range of Shh functionality and are required for the development of protein gradients important in tissue morphogenesis [9, 13]. Canonical signaling of Shh is mediated by a multicomponent receptor complex that includes Patched (PTCH1, PTCH2) and Smoothened (SMO) [14].

Reference

[1]. Briscoe, J. and P.P. Therond (2013) Mol. Cell. Biol. 14:416.

[2]. Aviles, E.C. et al. (2013) Front. Cell. Neurosci. 7:86.

[3]. Xie, J. et al. (2013) OncoTargets Ther. 6:1425.

[4]. Marigo, V. et al. (1995) Genomics 28:44.

[5]. Zeng, X. et al. (2001) Nature 411:716.

[6]. Feng, J. et al. (2004) Development 131:4357.

[7]. Goetz, J.A. et al. (2006) J. Biol. Chem. 281:4087.

[8]. Pepinsky, R.B. et al. (1998) J. Biol. Chem. 273:14037.

[9]. Pepinsky, R.B. et al. (1998) J. Biol. Chem. 273:14037.

[10]. Chen, M.-H. et al. (2004) Genes Dev. 18:641.

[11]. Etheridge, L.A. et al. (2010) Development 137:133.

[12]. Jakobs, P. et al. (2014) J. Cell Sci. 127:1726.

[13]. Dierker, T. et al. (2009) J. Biol. Chem. 284:8013.

[14]. Lewis, P.M. et al. (2001) Cell 105:599.

Description

Accession #

Q15465

Alternate Names

Shh;HHG1; HHG-1; HLP3; HPE3; MCOPCB5;Sonic Hedgehog; TPT; TPTPS

Source

Human embryonic kidney cell, HEK293-derived human Sonic Hedgehog/Shh protein

Protein sequence

Cys24-Gly197

M.Wt

19.6 kDa

Appearance

Solution protein.

Stability & Storage

Avoid repeated freeze-thaw cycles. It is recommended that the protein be aliquoted for optimal storage. 3 years from date of receipt, -20 to -70 °C as supplied.

Concentration

0. 2 mg/mL

Formulation

Dissolved in sterile PBS buffer.

Reconstitution

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. This solution can be diluted into other aqueous buffers.

Biological Activity

Measured by its ability to induce alkaline phosphatase production by C3H10T1/2 mouse embryonic fibroblast cells. The EC50 for this effect is typically 5-15 ng/mL.

Shipping Condition

Shipping with dry ice.

Handling

Centrifuge the vial prior to opening.

Usage

For Research Use Only! Not to be used in humans.

Quality Control

Quality Control & DataSheet

View current batch:
    Purity > 95%, determined by SDS-PAGE.
    Endotoxin: <0.010 EU per 1 ug of the protein by the LAL method.
  • Datasheet